Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2025-12-25 @ 2:05 PM
NCT ID:
NCT01458366
Group ID:
EG004
Title:
Bendamustine at MTD
Description:
Phase II: Given via IV on Days 1 and 2 of each cycle at the maximum-tolerated dose level found in the Phase I portion of the study.
Ofatumumab: Phase II
* Cycle 1: 300 mg via IV on Day 1 and 1000 mg via IV on Day 3
* Cycles 2 and 3: 1000 mg via IV on Day 1
Carboplatin: Phase II: AUC 5 via IV on Day 2 of each cycle
Etoposide: Phase II: 100 mg/m2 via IV on Days 1, 2, and 3 of each cycle
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
27
Other Number Affected:
11
Other Number At Risk:
27
Study:
NCT01458366
Results Section:
NCT01458366
Adverse Events Module:
NCT01458366